↓ Skip to main content

Cochrane Database of Systematic Reviews

Antipsychotic medication for childhood-onset schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
1 policy source
twitter
8 tweeters

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
186 Mendeley
Title
Antipsychotic medication for childhood-onset schizophrenia
Published in
Cochrane database of systematic reviews, July 2007
DOI 10.1002/14651858.cd004027.pub2
Pubmed ID
Authors

Eilis Kennedy, Ajit Kumar, Soumitra S Datta

Abstract

Childhood-onset schizophrenia is schizophrenia with onset prior to the age of 13 years. Although it is rare, people who suffer from schizophrenia at an early age appear to have a clinically severe form of the illness with poor long-term prognosis. Antipsychotic medication is one way of managing this rare but serious mental illness.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
United States 1 <1%
Unknown 184 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 15%
Student > Master 24 13%
Researcher 23 12%
Student > Ph. D. Student 18 10%
Student > Doctoral Student 15 8%
Other 30 16%
Unknown 48 26%
Readers by discipline Count As %
Medicine and Dentistry 61 33%
Psychology 25 13%
Nursing and Health Professions 12 6%
Social Sciences 7 4%
Neuroscience 4 2%
Other 24 13%
Unknown 53 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2016.
All research outputs
#4,396,740
of 22,669,724 outputs
Outputs from Cochrane database of systematic reviews
#6,735
of 12,296 outputs
Outputs of similar age
#12,447
of 67,488 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 76 outputs
Altmetric has tracked 22,669,724 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,488 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.